From the pharmacophore to the homology model of the benzodiazepine receptor: the indolyglyoxylamides affair.
Interaction between the so-called benzodiazepine receptor (BzR) and the chemically heterogeneous class of its ligands is still one of the most challenging objects of theoretical studies. In the mid-90s our group began to collaborate with Prof. Antonio Da Settimo and coworkers to a project of synthesis and biological evaluation of indolylglyoxylamides designed as BzR ligands. Herein we review our efforts in designing these compounds and in interpreting their structureaffinity relationships. Our investigations were carried out for years by adopting the pharmacophore/topological model for BzR ligands set up by Cook's group. In an attempt to rationalize some puzzling structure-affinity relationships we speculated in 1998 that our ligands interact with the BzR by assuming one of two alternative binding modes (called "A" and "B") depending on whether or not they were substituted at the 5-position of the indole nucleus. Such a model received support from a considerable amount of experimental data accumulated throughout our researches. About a decade later, docking calculations performed on a homology-built model of the  1 BzR subtype were found in agreement with the hypothesis of mode A and mode B of binding accessible to 5-H and, respectively, 5-Cl/NO2 indole derivatives.
Dipartimento di Chimica Farmaceutica e Tossicologica, Università di Napoli "Federico II", Naples, Italy.
Barbara
B
Cosimelli
Sandro
S
Cosconati
Luciana
L
Marinelli
Ettore
E
Novellino
Giovanni
G
Greco
D000577:Amides / Q000737:chemistry* / Q000494:pharmacology; D014151:Anti-Anxiety Agents / Q000737:chemistry* / Q000494:pharmacology; D001665:Binding Sites; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D058785:GABA-A Receptor Agonists / Q000737:chemistry / Q000494:pharmacology; D058787:GABA-A Receptor Antagonists / Q000737:chemistry / Q000494:pharmacology; D006038:Glyoxylates / Q000737:chemistry* / Q000494:pharmacology; D006801:Humans; D006993:Hypnotics and Sedatives / Q000737:chemistry* / Q000494:pharmacology; D007211:Indoles / Q000737:chemistry* / Q000494:pharmacology; D008024:Ligands; D008958:Models, Molecular; D011485:Protein Binding; D021122:Protein Subunits / Q000819:agonists / Q000037:antagonists & inhibitors / Q000378:metabolism; D011963:Receptors, GABA-A / Q000378:metabolism*; D013329:Structure-Activity Relationship
D000577:Amides; D014151:Anti-Anxiety Agents; D058785:GABA-A Receptor Agonists; D058787:GABA-A Receptor Antagonists; D006038:Glyoxylates; D006993:Hypnotics and Sedatives; D007211:Indoles; D008024:Ligands; D021122:Protein Subunits; D011963:Receptors, GABA-A